Characteristics and 9-month outcomes of discharged methadone maintenance clients

Journal of Substance Abuse Treatment

Volumn 40, Issue 2, 2011, Pages 165-174

  Coviello, Donna M ^a   Zanis, Dave A ^a,b   Wesnoski, Susan A ^a   Lynch, Kevin G ^a   Drapkin, Michelle ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Methadone maintenance treatment; Treatment discharge; Treatment reengagement

Indexed keywords

METHADONE; SEDATIVE AGENT;

ADULT; ARTICLE; CASE MANAGEMENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; EMPLOYMENT STATUS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERVIEW; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL HISTORY; MENTAL HOSPITAL; METHADONE TREATMENT; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; SEX DIFFERENCE; VETERAN;

ADULT; CASE MANAGEMENT; COMMUNITY-INSTITUTIONAL RELATIONS; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; MALE; MARITAL STATUS; METHADONE; MIDDLE AGED; NARCOTICS; PATIENT DISCHARGE; REFERRAL AND CONSULTATION; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNEMPLOYMENT;

EID: 78751706210     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.09.007     Document Type: Article

References (52)

1. Amaro H. An expensive policy: The impact of inadequate funding for substance abuse treatment. American Journal of Public Health 1999, 89:657-659.
2. Anglin M.D., Speckart G.R., Booth M.W., Ryan T.M. Consequences and costs of shutting off methadone. Addictive Behaviors 1989, 14:307-326.
3. Ball J.C., Ross A. The effectiveness of methadone maintenance treatment 1991, Springer-Verlag, New York.
4. Bell J., Burrell T., Indig D., Gilmour S. Cycling in and out of treatment; Participation in methadone treatment in NSW, 1990-2002. Drug and Alcohol Dependence 2006, 81:55-61.
5. Booth R.E., Kwiatkowski C., Iguchi M.Y., Pinto F., John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports 1998, 113:116-128.
6. Caplehorn J.R.M., Dalton M.S., Haldar F., Petrenas A., Nisbet J.G. Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use Misuse 1996, 31:177-196.
7. Carroll K.M., Rounsaville B.J. Contrast of treatment-seeking and untreated cocaine abusers. Archives of General Psychiatry 1992, 49:464-471.
8. Coviello D.M., Zanis D.A., Wesnoski S.A., Alterman A.I. The effectiveness of outreach case management in re-enrolling discharged methadone patients. Drug and Alcohol Dependence 2006, 85:56-65.
9. Dennis M.L., Scott C.K., Funk R. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning 2003, 26:339-352.
10. Derogatis L.R. SCL-90-R: Symptom Checklist-90-R. Administration, Scoring and Procedures Manual 1994, National Computer Systems, Minneapolis, MN. 3rd ed.
11. Esteban J., Gimeno C., Barril J., Aragones A., Climent J.M., de la Cruz Pellin M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence 2003, 70:193-200.
12. Fischer B., Cruz M.F., Patra J., Rehm J. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN). Journal of Substance Abuse Treatment 2008, 34:340-346.
13. Goldstein M.F., Deren S., Kang S.Y., Des Jarlais D.C., Magura S. Evaluation of an alternative program for MMTP drop-outs: Impact on treatment re-entry. Drug and Alcohol Dependence 2002, 66:181-187.
14. Gossop M., Green L., Phillips G., Bradley B. Lapse, relapse and survival among opiate addicts after treatment: A prospective follow-up study. British Journal of Psychiatry 1989, 154:348-353.
15. Grella C.E., Hser Y.I., Hsieh S.C. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. Journal of Substance Abuse Treatment 2003, 25:145-154.
16. Gronbladh L., Ohlund L.S., Gunne L.M. Morality in heroin addiction: Impact of methadone treatment. Acta Psychiatrica Scandinavica 1990, 82:223-227.
17. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, John Wiley and Sons, New York. 2nd ed.
18. Hser Y.I., Anglin M.D., Liu Y. A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. Substance Use & Misuse 1990, 25:1295-1315.
19. Hser Y.I., Maglione M., Polinsky M.L., Anglin M.D. Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 1998, 15:213-220.
20. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11:261-278.
21. Hubbard R.L., Marsden M.E. Relapse to use of heroin, cocaine, and other drugs in the first year after treatment. National Institute on Drug Abuse Research Monograph Series 1986, 72:157-166.
22. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginsburg H.M. Drug abuse treatment: A national study of effectiveness 1989, University of Northern Carolina Press, Chapel Hill, NC.
23. Humphreys K., Moos R., Cohen C. Social and community resources and long-term recovery from treated and untreated alcoholism. Journal of Studies on Alcohol 1997, 58:231-238.
24. Kleyn J., Lake E.S. Factors associated with willingness to enter drug treatment: Some implications for policy. AIDS & Public Policy Journal 1990, 5:112-116.
25. Kosten T.R., Rounsaville B.J., Kleber H.D. A 2.5 year follow-up of treatment retention and reentry among opioid addicts. Journal of Substance Abuse Treatment 1986, 3:181-189.
26. Luchansky B., He L., Krupski A., Stark K.D. Predicting readmission to substance abuse treatment using state information systems: The impact of client and treatment characteristics. Journal of Substance Abuse 2000, 12:255-270.
27. Magura S., Nwakeze P.C., Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998, 93:51-60.
28. Mattick R.P. National evaluation of pharmacotherapies for opioid dependence: Report of results and recommendations 2001, and the NEPOD Study Group, National Drug and Alcohol Research Centre, Sydney.
29. McLellan A.T., Luborsky L., Cacciola J., Griffith J.E., Evans F., Barr H.L., et al. New data from the Addiction Severity Index: Reliability and validity in three centers. Journal Nervous and Mental Disease 1985, 173:412-423.
30. McLellan A.T., Luborsky L., O'Brien C.P., Woody G.E. An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease 1980, 168:26-33.
31. Metzger D.S., Woody G.E., Druley P., O'Brien C.P., McLellan A.T., Williams J., et al. Psychiatric symptoms, high risk behaviors and HIV positivity among methadone patients. National Institute on Drug Abuse Research Monograph Series 1991, 490-491.
32. Metzger D.S., Woody G.E., McLellan A.T., Druley P., DePhillipis D., O'Brien C.P., et al. HIV seroconversion among in and out of treatment intravenous drug users: An 18-month prospective follow-up. AIDS 1993, 6:1049-1056.
33. Moos R.H., Mertens J.R., Brennan P.L. Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. Journal of Studies on Alcohol 1994, 55:561-570.
34. Rhoades H.M., Creson D., Elk R., Schimitz J., Grabowski J. Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency. American Journal of Public Health 1998, 88:34-39.
35. Schauenburg H., Strack M. Measuring psychotherapeutic change with the symptom checklist SCL 90 R. Psychotherapy and Psychosomatics 1999, 68:199-206.
36. Schutz C.G., Rapiti E., Vlahov D., Anthony J.C. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injection drug users. Drug and Alcohol Dependence 1994, 36:129-138.
37. Schwartz R.P., McKenzie M., Rich J.D. Opioid addiction and incarceration: An overview. Medicine and Health/Rhode Island 2007, 90:157-158.
38. Scott C.K., Dennis M.L. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction 2009, 104:959-971.
39. Scott C.K., Foss M.A., Dennis M.L. Factors influencing initial and longer-term responses to substance abuse treatment: A path analysis. Evaluation and Program Planning 2003, 26:287-295.
40. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., et al. Methadone maintenance vs.180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association 2000, 283:1303-1310.
41. Shadish W.R., Cook T.D., Campbell D.T. Experimental and quasi-experimental designs for generalized causal inference 2002, 623. Houghton-Mifflin, Boston.
42. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000, 14:2035-2043.
43. Sheerin I., Green T., Sellman D., Adamson S., Deering D. Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. New Zealand Medical Journal 2004, 117:1-10.
44. Simoens S., Ludbrook A., Matheson C., Bond C. Pharmaco-economics of community maintenance for opiate dependence: A review of evidence and methodology. Drug and Alcohol Dependence 2006, 84:28-39.
45. Simpson D.D., Joe G.W., Broome K.M. A national 5-year follow-up of treatment outcomes for cocaine dependence. Archives of General Psychiatry 2002, 59:538-544.
46. Simpson D.D., Joe G.W., Broome K.M., Hiller M.L., Knight K., Rowan-Szal G.A. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11:279-293.
47. Stark M.J. Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review 1992, 12:93-116.
48. Stout R.L., Rubin A., Zwick W., Zywaik W., Bellino L. Optimizing the cost-effectiveness of alcohol treatment: A rationale for extended case monitoring. Addictive Behaviors 1999, 24:17-35.
49. Tingey R.C., Lambert M.J., Burlingame G.M., Hansen N.B. Assessing clinical significance: Proposed extensions to method. Psychotherapy Research 1996, 6:109-123.
50. Tuten M., Jones H.E. A partner's drug-using status impacts women's drug treatment outcomes. Drug and Alcohol Dependence 2003, 70:327-330.
51. Zanis D.A., McLellan A.T., Alterman A.I., Cnaan R.A. Efficacy of enhanced outreach counseling to reenroll high risk drug users 1 year after discharge from treatment. American Journal of Psychiatry 1996, 153:1095-1096.
52. Zanis D.A., Woody G.E. One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 1998, 52:257-260.